Expression of Caspase 14 and Filaggrin in Oral Squamous Carcinoma

Head and Neck Pathology

Volumn 7, Issue 4, 2013, Pages 327-333

  Scharenberg, Constance ^a   Eckardt, André ^a   Tiede, Christina ^a   Kreipe, Hans ^a   Hussein, Kais ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Caspase 14; Filaggrin; Oral squamous carcinoma

Indexed keywords

CASP14 PROTEIN, HUMAN; CASPASE; FILAGGRIN; INTERMEDIATE FILAMENT PROTEIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BIOSYNTHESIS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; MOUTH TUMOR; PAPILLOMAVIRUS INFECTION; PATHOLOGY; SQUAMOUS CELL CARCINOMA; VERY ELDERLY; VIROLOGY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CASPASES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERMEDIATE FILAMENT PROTEINS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84886749808     PISSN: 1936055X     EISSN: 19360568     Source Type: Journal    
DOI: 10.1007/s12105-013-0445-0     Document Type: Article

References (35)

1. van de Craen M, van Loo G, Pype S, van Criekinge W, van den brande I, Molemans F, Fiers W, Declercq W, Vandenabeele P. Identification of a new caspase homologue: caspase-14. Cell Death Differ. 1998;5: 838-46.
2. Kuechle MK, Predd HM, Fleckman P, Dale BA, Presland RB. Caspase-14, a keratinocyte specific caspase: mRNA splice variants and expression pattern in embryonic and adult mouse. Cell Death Differ. 2001;8: 868-70.
3. Alibardi L, Tschachler E, Eckhart L. Distribution of caspase-14 in epidermis and hair follicles is evolutionarily conserved among mammals. Anat Rec A Discov Mol Cell Evol Biol. 2005;286: 962-73.
4. Kam DW, Charles AK, Dharmarajan AM. Caspase-14 expression in the human placenta. Reprod Biomed Online. 2005;11: 236-43.
5. White LJ, Declercq W, Arfuso F, Charles AK, Dharmarajan AM. Function of caspase-14 in trophoblast differentiation. Reprod Biol Endocrinol. 2009;7: 98.
6. Raymond AA, Méchin MC, Nachat R, Toulza E, Tazi-Ahnini R, Serre G, Simon M. Nine procaspases are expressed in normal human epidermis, but only caspase-14 is fully processed. Br J Dermatol. 2007;156: 420-7.
7. Wu M, Kodani I, Dickinson D, Huff F, Ogbureke KU, Qin H, Arun S, Dulebohn R, Al-Shabrawey M, Tawfik A, Prater S, Lewis J, Wataha J, Messer R, Hsu S. Exogenous expression of caspase-14 induces tumor suppression in human salivary cancer cells by inhibiting tumor vascularization. Anticancer Res. 2009;29: 3811-8.
8. Hsu S, Yamamoto T, Borke J, Walsh DS, Singh B, Rao S, Takaaki K, Nah-Do N, Lapp C, Lapp D, Foster E, Bollag WB, Lewis J, Wataha J, Osaki T, Schuster G. Green tea polyphenol-induced epidermal keratinocyte differentiation is associated with coordinated expression of p57/KIP2 and caspase 14. J Pharmacol Exp Ther. 2005;312: 884-90.
9. Lippens S, Kockx M, Denecker G, Knaapen M, Verheyen A, Christiaen R, Tschachler E, Vandenabeele P, Declercq W. Vitamin D3 induces caspase-14 expression in psoriatic lesions and enhances caspase-14 processing in organotypic skin cultures. Am J Pathol. 2004;165: 833-41.
10. Asselin-Labat ML, Sutherland KD, Vaillant F, Gyorki DE, Wu D, Holroyd S, Breslin K, Ward T, Shi W, Bath ML, Deb S, Fox SB, Smyth GK, Lindeman GJ, Visvader JE. Gata-3 negatively regulates the tumor-initiating capacity of mammary luminal progenitor cells and targets the putative tumor suppressor caspase-14. Mol Cell Biol. 2011;31: 4609-22.
11. Ballaun C, Karner S, Mrass P, Mildner M, Buchberger M, Bach J, Ban J, Harant H, Tschachler E, Eckhart L. Transcription of the caspase-14 gene in human epidermal keratinocytes requires AP-1 and NFkappaB. Biochem Biophys Res Commun. 2008;371: 261-6.
12. Denecker G, Ovaere P, Vandenabeele P, Declercq W. Caspase-14 reveals its secrets. J Cell Biol. 2008;180: 451-8.
13. Eckhart L, Tschachler E. Cuts by caspase-14 control the proteolysis of filaggrin. J Invest Dermatol. 2011;131: 2173-5.
14. Bergeron L, Gondran C, Oberto G, Garcia N, Botto JM, Cucumel K, Dal Farra C, Domloge N. Skin presenting a higher level of caspase-14 is better protected from UVB irradiation according to in vitro and in vivo studies. J Cosmet Dermatol. 2012;11: 111-21.
15. Denecker G, Hoste E, Gilbert B, Hochepied T, Ovaere P, Lippens S, van den Broecke C, van Damme P, D'Herde K, Hachem JP, Borgonie G, Presland RB, Schoonjans L, Libert C, Vandekerckhove J, Gevaert K, Vandenabeele P, Declercq W. Caspase-14 protects against epidermal UVB photodamage and water loss. Nat Cell Biol. 2007;9: 666-74.
16. Hoste E, Kemperman P, Devos M, Denecker G, Kezic S, Yau N, Gilbert B, Lippens S, De Groote P, Roelandt R, van Damme P, Gevaert K, Presland RB, Takahara H, Puppels G, Caspers P, Vandenabeele P, Declercq W. Caspase-14 is required for filaggrin degradation to natural moisturizing factors in the skin. J Invest Dermatol. 2011;131: 2233-41.
17. Sandilands A, Sutherland C, Irvine AD, McLean WH. Filaggrin in the frontline: role in skin barrier function and disease. J Cell Sci. 2009;122: 1285-94.
18. Aho S, Harding CR, Lee JM, Meldrum H, Bosko CA. Regulatory role for the profilaggrin N-terminal domain in epidermal homeostasis. J Invest Dermatol. 2012. doi: 10. 1038/jid. 2012. 174.
19. Yamamoto M, Kamata Y, Iida T, Fukushima H, Nomura J, Saito M, Tajima M, Okubo Y, Momoi T, Tsuboi R, Hibino T. Quantification of activated and total caspase-14 with newly developed ELISA systems in normal and atopic skin. J Dermatol Sci. 2011;61: 110-7.
20. Bayo P, Sanchis A, Bravo A, Cascallana JL, Buder K, Tuckermann J, Schütz G, Pérez P. Glucocorticoid receptor is required for skin barrier competence. Endocrinology. 2008;149: 1377-88.
21. Koenig U, Sommergruber W, Lippens S. Aberrant expression of caspase-14 in epithelial tumors. Biochem Biophys Res Commun. 2005;335: 309-13.
22. Krajewska M, Kim H, Shin E, Kennedy S, Duffy MJ, Wong YF, Marr D, Mikolajczyk J, Shabaik A, Meinhold-Heerlein I, Huang X, Banares S, Hedayat H, Reed JC, Krajewski S. Tumor-associated alterations in caspase-14 expression in epithelial malignancies. Clin Cancer Res. 2005;11: 5462-71.
23. Fang HY, Chen CY, Hung MF, Hsiao YT, Chiang TC, Lin TY, Chang HW, Chow KC, Ko WJ. Caspase-14 is an anti-apoptotic protein targeting apoptosis-inducing factor in lung adenocarcinomas. Oncol Rep. 2011;26: 359-69.
24. Yoo NJ, Soung YH, Lee SH, Jeong EG, Lee SH. Mutational analysis of caspase-14 gene in common carcinomas. Pathology. 2007;39: 330-3.
25. Hsu S, Qin H, Dickinson D, Xie D, Bollag WB, Stoppler H, Pearl H, Vu A, Watkins M, Koehler M, Schuster G. Expression of caspase-14 reduces tumorigenicity of skin cancer cells. In Vivo. 2007;21: 279-83.
26. Kazem S, van der Meijden E, Struijk L, de Gruijl FR, Feltkamp MC. Human papillomavirus 8 E6 disrupts terminal skin differentiation and prevents pro-Caspase-14 cleavage. Virus Res. 2012;163: 609-16.
27. Bockmeyer CL, Maegel L, Janciauskiene S, Rische J, Lehmann U, Maus UA, Nickel N, Haverich A, Hoeper MM, Golpon HA, Kreipe H, Laenger F, Jonigk D. Plexiform vasculopathy of severe pulmonary arterial hypertension and microRNA expression. J Heart Lung Transpl. 2012;31: 764-72.
28. Pilatz A, Altinkilic B, Rusz A, Izykowski N, Traenkenschuh W, Rische J, Lehmann U, Herbst C, Maegel L, Becker J, Weidner W, Jonigk D. Role of human papillomaviruses in persistent and glucocorticoid-resistant juvenile phimosis. J Eur Acad Dermatol Venereol. 2012. doi: 10. 1111/j. 1468-3083. 2012. 04542. x.
29. Kristoffersen AK, Enersen M, Kverndokk E, Sunde PT, Landin M, Solheim T, Olsen I, Grinde B. Human papillomavirus subtypes in oral lesions compared to healthy oral mucosa. J Clin Virol. 2012;53: 364-6.
30. Theophile K, Hussein K, Kreipe H, Bock O. Expression profiling of apoptosis-related genes in megakaryocytes: BNIP3 is downregulated in primary myelofibrosis. Exp Hematol. 2008;36: 1728-38.
31. Grosso M, Lentini M, Bellizi De Marco E, Petracca R, Leoncini P, Carrozza G. Immunohistochemical localization of filaggrin in benign and malignant lesions of the human oral mucosa. Basic Appl Histochem. 1990;34: 51-8.
32. Lara C, Serra V, Marzo C, Valcuende F, Castells A, Bonilla-Musoles FM. Immunohistochemical localization of filaggrin in benign, premalignant and malignant cervical tissue. Arch Gynecol Obstet. 1994;255: 73-9.
33. Turatti E, da CostaNeves A, de Magalhães MH, de Sousa SO. Assessment of c-Jun, c-Fos and cyclin D1 in premalignant and malignant oral lesions. J Oral Sci. 2005;47: 71-6.
34. Nakayama H, Ikebe T, Beppu M, Shirasuna K. High expression levels of nuclear factor kappaB, IkappaB kinase alpha and Akt kinase in squamous cell carcinoma of the oral cavity. Cancer. 2001;92: 3037-44.
35. Nakayama H, Ikebe T, Shirasuna K. Effects of IkappaB kinase alpha on the differentiation of squamous carcinoma cells. Oral Oncol. 2005;41: 729-37.